What are the infectious risks with disease-modifying drugs for multiple sclerosis and how to reduce them? A review of literature
Valérie Pourcher
Topics & Concepts
MedicineMultiple sclerosisIntensive care medicineVaccinationDiseaseImmunizationInfectious disease (medical specialty)Clinical trialAsymptomaticImmunologyImmune systemInternal medicineMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersSARS-CoV-2 and COVID-19 Research